Evidence map›Paper›PMID 24871948›Full record

ArticleDevelopmental cell2014

Estrogen defines the dorsal-ventral limit of VEGF regulation to specify the location of the hemogenic endothelial niche.

Kelli J Carroll, Virginie Esain, Maija K Garnaas, Mauricio Cortes, Michael C Dovey, Sahar Nissim, Gregory M Frechette, Sarah Y Liu, Wanda Kwan, Claire C Cutting and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Learning from Zebrafish Hematopoiesis.Advances in experimental medicine and biology · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Kelli J CarrollBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Virginie EsainBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Maija K GarnaasBrigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Mauricio CortesBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Michael C DoveyBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Sahar NissimBrigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Gregory M FrechetteBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Sarah Y LiuBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Wanda KwanBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Claire C CuttingBrigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
James M HarrisBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Daniel A GorelickUniversity of Alabama at Birmingham, Birmingham, AL 35294, USA.
Marnie E HalpernCarnegie Institution for Science, Baltimore, MD 21218, USA.
Nathan D LawsonUniversity of Massachusetts Medical School, Worcester, MA 01605, USA.
Wolfram GoesslingBrigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address: wgoessling@partners.org.
Trista E NorthBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address: tnorth@bidmc.harvard.edu.
Harvard University · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USCarnegie Institution for Science · USDana-Farber Cancer Institute · USUniversity of Alabama at Birmingham · USUniversity of Massachusetts Chan Medical School · US

Funding

ALIMENTARY TRACT RESEARCH IN HEALTH AND DISEASET32DK007533 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BLUMBERG, RICHARD S · 1986 to 2020
$5.3M
Estrogen Regulation of Hepatic GrowthR01DK090311 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2011 to 2020
$4.9M
Metabolic regulation of hematopoietic stem cell specification and functionR01DK098241 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI NORTH, TRISTA E. · 2014 to 2018
$2.0M
Defining Estrogenic Regulation of Hematopoietic Stem Cell Formation and FunctionR21OD012227 · OD · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NORTH, TRISTA E. · 2012 to 2013
$466k
NIDDK NIH HHS R01 DK090311NIDDK NIH HHS R01 DK098241NIDDK NIH HHS T32 DK007533NIH HHS R21 OD012227
6 · The paper itself

Abstract

Genetic control of hematopoietic stem and progenitor cell (HSPC) function is increasingly understood; however, less is known about the interactions specifying the embryonic hematopoietic niche. Here, we report that 17β-estradiol (E2) influences production of runx1+ HSPCs in the AGM region by antagonizing VEGF signaling and subsequent assignment of hemogenic endothelial (HE) identity. Exposure to exogenous E2 during vascular niche development significantly disrupted flk1+ vessel maturation, ephrinB2+ arterial identity, and specification of scl+ HE by decreasing expression of VEGFAa and downstream arterial Notch-pathway components; heat shock induction of VEGFAa/Notch rescued E2-mediated hematovascular defects. Conversely, repression of endogenous E2 activity increased somitic VEGF expression and vascular target regulation, shifting assignment of arterial/venous fate and HE localization; blocking E2 signaling allowed venous production of scl+/runx1+ cells, independent of arterial identity acquisition. Together, these data suggest that yolk-derived E2 sets the ventral boundary of hemogenic vascular niche specification by antagonizing the dorsal-ventral regulatory limits of VEGF.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsBenzhydryl CompoundsBisphenol A CompoundsCore Binding Factor Alpha 2 SubunitEphrin-B2EstradiolEstrogen AntagonistsEstrogensEthinyl EstradiolFulvestrantGenisteinHeat-Shock ResponseHemangioblastsHematopoietic Stem CellsMorpholinosBasic Helix-Loop-Helix ProteinsBenzhydryl Compoundsbisphenol ABisphenol A CompoundsCore Binding Factor Alpha 2 SubunitEphrin-B2EstradiolEstrogen AntagonistsEstrogensEthinyl EstradiolFulvestrantGenisteinMorpholinosPhenolsProto-Oncogene ProteinsReceptors, EstradiolReceptors, Notchrunx1 protein, zebrafishtal1 protein, zebrafishT-Cell Acute Lymphocytic Leukemia Protein 1Vascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Vegfaa protein, zebrafishZebrafish Proteins

Identifiers

PMID24871948
PMCPMC4469361
OpenAlexW2066890095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.